Takeshi Yanagita
Overview
Explore the profile of Takeshi Yanagita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kato A, Takahashi H, Asai H, Uehara S, Harata S, Fujii Y, et al.
Oncol Rep
. 2024 Dec;
53(2.
PMID: 39717947
BH3 mimetics are small‑molecule inhibitors of the antiapoptotic Bcl‑2 family and have therapeutic efficacy against hematological malignancies. BH3 mimetic A‑1331852 suppresses colorectal cancer cell proliferation. Progressive resistance to the widely...
2.
Uehara S, Ushigome H, Takahashi H, Asai H, Kato A, Fujii Y, et al.
Asian J Endosc Surg
. 2024 Sep;
17(4):e13387.
PMID: 39340128
Extraperitoneal colostomy is often selected to reduce the risk of parastomal hernia. However, its closure surgery is rare and seldom reported. Here, we report our unique experience with robotic left...
3.
Watanabe K, Takahashi H, Uehara S, Kato A, Fujii Y, Yanagita T, et al.
Surg Case Rep
. 2024 Jul;
10(1):164.
PMID: 38951358
Background: In laparoscopic colorectal surgery, accurate localization of a tumor is essential for ensuring an adequate ablative margin. Therefore, a new method, near-infrared laparoscopy combined with intraoperative colonoscopy, was developed...
4.
Nakamura D, Yanagita T, Fujii Y, Watanabe K, Suzuki T, Ushigome H, et al.
Surg Case Rep
. 2024 May;
10(1):105.
PMID: 38691233
Background: The standard treatment for colorectal cancer consists of surgery and chemotherapy, which can be combined to improve outcomes. Immune checkpoint inhibitors (ICI) are a significant advancement in the standard...
5.
Watanabe K, Ushigome H, Takahashi H, Kato A, Harata S, Fujii Y, et al.
J Anus Rectum Colon
. 2024 Feb;
8(1):43-47.
PMID: 38313748
Although robotic rectal resections are now widely performed, there are few robotic suction tools that can be easily used by console surgeons. It can therefore be difficult to maintain a...
6.
Kusudo N, Suzuki T, Uehara S, Kato A, Fujii Y, Harata S, et al.
Gan To Kagaku Ryoho
. 2024 Jan;
51(1):90-92.
PMID: 38247102
The patient was a 68-year-old woman who was on hemodialysis due to systemic amyloidosis and nephrotic syndrome. Biopsy revealed amyloid deposition in the stomach, duodenum, and colon. A transverse colon...
7.
Ushigome H, Takahashi H, Harata S, Fujii Y, Watanabe K, Yanagita T, et al.
Surg Today
. 2023 Sep;
54(3):282-287.
PMID: 37777607
It has been pointed out that robotic surgery is more time-consuming than laparoscopic surgery, and a major challenge for the future is educating young surgeons while maintaining the surgical quality....
8.
Nakai N, Maeda A, Yanagita T, Suzuki T, Maeda Y, Hirokawa T, et al.
Anticancer Res
. 2023 Apr;
43(5):2333-2341.
PMID: 37097654
Background/aim: Vascular endothelial growth factor (VEGF) influences colorectal cancer (CRC) progression and is a key target in the treatment for metastatic CRC. However, the oncological impact of preoperative circulating VEGF...
9.
Harata S, Takahashi H, Ando N, Kato A, Watanabe K, Yanagita T, et al.
Surg Case Rep
. 2023 Apr;
9(1):64.
PMID: 37095273
Background: Spontaneous regression (SR) of cancer occurs in 1 in 60,000-100,000 patients. This phenomenon has been reported in almost all cancer types, most commonly neuroblastoma, renal cell carcinoma, malignant melanoma,...
10.
Harata S, Suzuki T, Takahashi H, Hirokawa T, Kato A, Watanabe K, et al.
Oncol Rep
. 2023 Feb;
49(3).
PMID: 36734271
Ataxia telangiectasia and Rad3‑related (ATR) is a kinase that repairs DNA damage. Although inhibitors that selectively target ATR have been developed, their effectiveness in colorectal cancer has not been widely...